30 Hamilton B, Salzman K, Wiggins R, Harnsberger H. 2003. Earring lesions of the parotid tail. Am J Neuroradiol 24:1757–1764.
31 Hasson O. 2010. Modern sialography for screening of salivary gland obstruction. J Oral Maxillofac Surg 68:276–280.
32 Henkelman R, Watts J, Kucharczyk W. 1991. High signal intensity in MR images in calcified brain tissue. Radiology 179:199–206.
33 Holliday R. 1998. Benign lymphoepithelial parotid cysts and hyperplastic cervical adenopathy in AIDS‐risk patients: A new CT appearance. Radiology 168:439–441.
34 Hopp E, Mortensen B, Kolbenstvedt A. 2004. Mylohyoid herniation of the sublingual gland diagnosed by magnetic resonance imaging. Dentom Radiol 33:351–353.
35 Hsu C, Lee C, Wang F, Fang C. 2003. Neurofibroma with increased uptake of F‐18‐fluoro‐2‐deoxy‐D‐glucose interpreted as a metastatic lesion. Ann Nucl Med 17:609–611.
36 Huang C, Damrose E, Bhuta S, Abemayor E. 2002. Kuttner tumor (chronic sclerosing sialadenitis). Am J Otolaryngol 23(6):394–397.
37 Ikeda K, Tsutomu K, Ha‐Kawa S et al. 1996. The usefulness of MR in establishing the diagnosis of parotid pleomorphic adenoma. Am J Neuroradiol 17:555–559.
38 Ikeda M, Motoori K, Hanazawa T et al. 2004. Warthin tumor of the parotid gland: Diagnostic value of MR imaging with histopathologic correlation. Am J Neuroradiol 25:1256–1262.
39 Ioannidis J, Lau J. 2003. 18F‐FDG PET for the diagnosis and grading of soft‐tissue sarcoma: A meta‐analysis. J Nucl Med 44:717–724.
40 Izumi M, Eguchi K, Hideki N et al. 1997. Premature fat deposition in the salivary glands associated with Sjogren's syndrome: MR and CT evidence. Am J Neuroradiol 18(5):951–958.
41 Jansisyanant P, Blanchaert R, Ord R. 2002. Intraoral minor salivary gland neoplasm: A single institution experience of 80 cases. Int J Oral Maxillofac Surg 31(3):257–261.
42 Jeong H, Chung M, Son Y et al. 2007. Role of 18‐F‐FDG PET/CT in management of high‐grade salivary gland malignancies. J Nucl Med 48:1237–1244.
43 Jhanvar Y, Straus D. 2006. The role of PET in lymphoma. J Nucl Med 47:1326–1334.
44 Kalinowski M, Heverhagen J, Rehberg E et al. 2002. Comparative study of MR sialography and digital subtraction sialography for benign salivary gland disorders. Am J Neuroradiol 23:1485–1492.
45 Kaneda T. 1996. MR of the submandibular gland: Normal and pathologic states. AJR 17:1575–1581.
46 Keyes J, Harkness B, Greven K et al. 1994. Salivary gland tumors: Pretherapy evaluation with PET. Radiology 192:99–102.
47 Kim HJ, Kim JS. 2018. Ultrasound‐guided Core needle biopsy in salivary glands: A meta‐analysis. Laryngoscope 128:118–125.
48 King A, Yeung D, Ahuja A et al. 2005. Salivary gland tumors at in‐vivo proton MR spectroscopy. Radiology 237:563–569.
49 Kinoshita T, Okitsu T. 2004. MR imaging findings of parotid tumors with pathologic diagnostic clues: A pictorial essay. Clin Imaging 28:93–101.
50 Kirshenbaum K, Nadimpalli S, Rehberg E et al. 1991. Benign lymphoepithelial parotid tumors in AIDS patients: CT and MR findings in nine cases. Am J Neuroradiol 12:271–274.
51 Koeller K, Alamo L, Adair C, Smirniotopoulos J. 1999. Congenital cystic masses of the neck: Radiologic‐pathologic characteristics. Radiographics 19:121–146.
52 Kurabayashi T, Ida M, Yasumoto M et al. 2000. MRI of ranulas. Neuroradiology 42(12):917–922.
53 Lin J, Martel W. 2001. Cross‐sectional imaging of peripheral nerve sheath tumors: Characteristics signs on CT, MR imaging and sonography. AJR 176:75–82.
54 Lowe L, Stokes L, Johnson J et al. 2001. Swelling at the angle of the mandible: Imaging of the pediatric parotid gland and periparotid region. Radiographics 21:1211–1227.
55 Macdonald A, Salzman K, Hansberger H. 2003. Giant ranula of the neck: Differentiation from cystic hygroma. Am J Neuroradiol 24:757–761.
56 MacManus M, Ryan G, Lau E, Wirth A, Hicks R. 2007. Positron emission tomography of stage IV mucosa‐associated lymphoid tissue lymphoma confined to the four major salivary glands. Aust Radiol 51:68–70.
57 Madani G, Beale T. 2006a. Inflammatory conditions of the salivary glands. Semin Ultrasound CT MRI 27:440–451.
58 Madani G, Beale T. 2006b. Tumors of the salivary glands. Semin Ultrasound CT MRI 27:452–464.
59 Makariou E, Pikis A, Harley E. 2003. Cystic hygroma of the neck: Associated with a growing venous aneurysm. Am J Neuroradiol 24:2102–2104.
60 Martin N, Serkers O, Mompoint D, Nahum H. 1992. Facial nerve neuromas: MR imaging‐report of four cases. Neuroradiology 34:62–67.
61 Martinoli C, Pretolesi F, Del Bono V et al. 1995. Benign lymphoepithelial parotid lesion in HIV‐positive patients: Spectrum of findings at gray‐scale and Doppler sonography. AJR 165:975–979.
62 Miyaki H, Matsumoto A, Hori Y et al. 2001. Warthin's tumor of parotid gland on Tc‐99m pertechnetate scintigraphy with lemon juice stimulation: Tc99m uptake, size, and pathologic correlation. Eur Radiol 11(12):2472–2478.
63 Moonis G, Patel P, Koshkareva Y et al. 2007. Imaging characteristics of recurrent pleomorphic adenoma of the parotid gland. Am J Neuroradiol 28:1532–1536.
64 Mosier KM. 2009. Diagnostic radiographic imaging for salivary endoscopy. Otolaryngol Clin North Am 42:949–972.
65 Motoori K, Yamamoto S, Ueda T et al. 2004. Inter‐ and intratumoral variability in magnetic resonance imaging of pleomorphic adenoma. J Comput Assist Tomogr 28:233–246.
66 Motoori K, Iida Y, Nagai Y et al. 2005. MR imaging of salivary duct carcinoma. Am J Neuroradiol 26:1201–1206.
67 Nakamoto Y, Tatsumi M, Hammoud D et al. 2005. Normal FDG distribution patterns in the head and neck: PET/CT evaluation. Radiology 234:879–885.
68 Novoa E, Gurrier N, Arnoux A, Kraft M. 2015. Diagnostic value of core needle biopsy and fine‐needle aspiration in salivary gland lesions. Head Neck 38:E346–E352.
69 Ollila DW, Foshag LJ, Essner R et al. 1999. Parotid region lymphatic mapping and sentinel lymphadenopathy for cutaneous melanoma. Ann Surg Oncol 6(2):150–154.
70 Otsuka H, Graham M, Kogame M, Nishitani H. 2005. The impact of FDG‐PET in the management of patients with salivary gland malignancy. Ann Nucl Med 19(8):691–694.
71 Patel R, Carlos R, Midia M, Mukherji S. 2004. Apparent diffusion coefficient mapping of the normal parotid gland and parotid involvement in patients with systemic connective tissue disorders. Am J Neuroradiol 25:16–20.
72 Patz E, Lowe V, Hoffman J et al. 1993. Focal pulmonary abnormalities: Evaluation with F‐18 fluorodeoxyglucose PET scanning. Radiology 188:487–490.
73 Roh J, Ryu C, Choi S et al. 2007. Clinical utility of 18F‐FDG PET for patients with salivary gland malignancies. J Nucl Med 48:240–246.
74 Rumboldt Z, Al‐Okkaili R, Deveikis J. 2005. perfusion CT for head and neck tumors: A pilot study. Am J Neuroradiol 26:1178–1185.
75 Schoder H, Yusuf E, Chao K et al. 2004. Clinical implications of different image reconstruction parameters for interpretation of whole‐body PET studies in cancer patients. J Nucl Med 45:559–566.
76 Shah G. 2002. MR imaging of salivary glands. Mag Reson Clin N Am 10:631–662.
77 Shah G, Fischbein N, Patel R, Mukherji S. 2003. Newer MR imaging techniques for head and neck. Magn Reson Clin N Am 11:449–469.
78 Sheedy S, Welker K, Delone D, Gilbertson J. 2006. CNS metastases of carcinoma ex pleomorphic adenoma of the parotid gland. Am J Neuroradiol 27:1483–1485.
79 Shimizu K, Iwai H, Ikeda K et al. 2005. Intraparotid facial nerve schwannoma: A report of five cases and an analysis of MR imaging results. Am J Neuroradiol 26:1328–1330.
80 Sigal R, Monnet O, De Baere T et al. 1992. Adenoid cystic carcinoma of the head and neck: Evaluation with MR imaging and clinical‐pathologic correlation in 27 patients. Radiology 184:95–101.
Читать дальше